IQV ▲ +2.9% - IQVIA Holdings Inc. $IQV - IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster IQVIA rose 2.9% today following an announcement highlighting its Predictive Clinical Development offering, which the company says enables pharmaceutical sponsors to accelerate treatment timelines and improve operational efficiency in bringing drugs to market. The efficiency gains and faster development pathways that IQVIA's service provides could expand the company's addressable market within its core clinical research business. 03-SEP-2026 04:18 PM ET